Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study.
Van de Vondel S, Baert F, Reenaers C, Vanden Branden S, Amininejad L, Dewint P, Van Moerkercke W, Rahier JF, Hindryckx P, Bossuyt P, Ferrante M; Belgian IBD Research and Development (BIRD). Van de Vondel S, et al. Among authors: hindryckx p. Inflamm Bowel Dis. 2018 Apr 23;24(5):1099-1105. doi: 10.1093/ibd/izx103. Inflamm Bowel Dis. 2018. PMID: 29668947 Free article.
Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.
De Vos M, Louis EJ, Jahnsen J, Vandervoort JG, Noman M, Dewit O, Dʼhaens GR, Franchimont D, Baert FJ, Torp RA, Henriksen M, Potvin PM, Van Hootegem PP, Hindryckx PM, Moreels TG, Collard A, Karlsen LN, Kittang E, Lambrecht G, Grimstad T, Koch J, Lygren I, Coche JC, Mana F, Van Gossum A, Belaiche J, Cool MR, Fontaine F, Maisin JM, Muls V, Neuville B, Staessen DA, Van Assche GA, de Lange T, Solberg IC, Vander Cruyssen BJ, Vermeire SA. De Vos M, et al. Among authors: hindryckx pm. Inflamm Bowel Dis. 2013 Sep;19(10):2111-7. doi: 10.1097/MIB.0b013e31829b2a37. Inflamm Bowel Dis. 2013. PMID: 23883959
Clinical trials in luminal Crohn's disease: a historical perspective.
Hindryckx P, Baert F, Hart A, Armuzzi A, Panès J, Peyrin-Biroulet L; Clinical Trial Committee Clincom of the European Crohn's and Colitis Organisation (ECCO). Hindryckx P, et al. J Crohns Colitis. 2014 Nov;8(11):1339-50. doi: 10.1016/j.crohns.2014.04.007. Epub 2014 May 17. J Crohns Colitis. 2014. PMID: 24841216 Review.
Clinical trials in ulcerative colitis: a historical perspective.
Hindryckx P, Baert F, Hart A, Magro F, Armuzzi A, Peyrin-Biroulet L; Clinical Trial Committee Clincom of the European Crohn’s and Colitis Organisation (ECCO). Hindryckx P, et al. J Crohns Colitis. 2015 Jul;9(7):580-8. doi: 10.1093/ecco-jcc/jjv074. Epub 2015 Apr 25. J Crohns Colitis. 2015. PMID: 25913641 Review.
Not a Usual Flare up of Ulcerative Colitis.
Neto R, Ferdinande L, Hindryckx P. Neto R, et al. Among authors: hindryckx p. Gastroenterology. 2015 Jun;148(7):1284-7. doi: 10.1053/j.gastro.2014.12.053. Epub 2015 Apr 30. Gastroenterology. 2015. PMID: 25936952 No abstract available.
Review article: dose optimisation of infliximab for acute severe ulcerative colitis.
Hindryckx P, Novak G, Vande Casteele N, Laukens D, Parker C, Shackelton LM, Narula N, Khanna R, Dulai P, Levesque BG, Sandborn WJ, D'Haens G, Feagan BG, Jairath V. Hindryckx P, et al. Aliment Pharmacol Ther. 2017 Mar;45(5):617-630. doi: 10.1111/apt.13913. Epub 2017 Jan 11. Aliment Pharmacol Ther. 2017. PMID: 28074618 Free PMC article. Review.
The safety of vedolizumab for the treatment of ulcerative colitis.
Novak G, Hindryckx P, Khanna R, Jairath V, Feagan BG. Novak G, et al. Among authors: hindryckx p. Expert Opin Drug Saf. 2017 Apr;16(4):501-507. doi: 10.1080/14740338.2017.1300251. Epub 2017 Mar 5. Expert Opin Drug Saf. 2017. PMID: 28276855 Review.
112 results